[Shift of focus in the financing of Hungarian drugs. Reimbursement for orphan drugs for treating rare diseases: financing of enzyme replacement therapy in Hungary]. [electronic resource]
Producer: 20150326Description: 1735-41 p. digitalISSN:- 0030-6002
- Compassionate Use Trials -- economics
- Drug Costs
- Enzyme Replacement Therapy -- economics
- Fabry Disease -- drug therapy
- Financing, Government -- legislation & jurisprudence
- Gaucher Disease -- drug therapy
- Glycogen Storage Disease Type II -- drug therapy
- Health Services Needs and Demand
- Humans
- Hungary
- Insurance Coverage
- Insurance, Health
- Mucopolysaccharidosis I -- drug therapy
- Mucopolysaccharidosis II -- drug therapy
- Orphan Drug Production -- economics
- Rare Diseases -- drug therapy
No physical items for this record
Publication Type: English Abstract; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.